Reuters logo
BRIEF-Oryzon Genomics to present positive preclinical data for ORY-2001 on Feb. 24
February 20, 2017 / 11:56 AM / 7 months ago

BRIEF-Oryzon Genomics to present positive preclinical data for ORY-2001 on Feb. 24

Feb 20 (Reuters) - Oryzon Genomics SA:

* To present preclinical data of therapeutic activity in multiple sclerosis of ORY-2001 on Feb. 24

* To present positive preclinical data for ORY-2001 which will expand data presented at London conference in Sept. 2016

Source text: bit.ly/2m3Iuv5 Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below